Blog
RSS FeedPosted by Michael Wonder on 18 Apr 2023
Added therapeutic benefit of top selling brand name drugs in Medicare
18 April 2023 - What was the added therapeutic benefit of the 50 top selling drugs in Medicare in 2020, ...
Posted by Michael Wonder on 05 Apr 2023
HHS finalises rule to strengthen Medicare, improve access to affordable prescription drug coverage and hold private insurance companies accountable to delivering quality health care for America’s seniors and people with disabilities
5 April 2023 - Thanks to President Biden’s new law to lower prescription drug costs, the final rule will also ...
Posted by Michael Wonder on 04 Apr 2023
Medicare non-compliance and fraud costing Australians
4 April 2023 - The Albanese Government has today released the findings of a review into the compliance system that underpins ...
Posted by Michael Wonder on 03 Apr 2023
Medicare system is ‘not fit for purpose’, review finds
4 April 2023 - Australia’s health funding system is “fragmented and disjointed” and in critical need of being simplified, says ...
Posted by Michael Wonder on 16 Mar 2023
First drugs facing Medicare price penalty are named
15 March 2023 - US lists 27 medications whose prices rose faster than inflation, triggering rebates under new law. ...
Posted by Michael Wonder on 16 Mar 2023
Pfizer will have to pay rebates to Medicare for five drugs under Biden plan to lower Rx costs
16 March 2023 - Five of Pfizer’s drugs will cost less for Medicare recipients starting next month as part of President ...
Posted by Michael Wonder on 14 Mar 2023
BMS, Pfizer, AbbVie drugs likely to face US price negotiation
13 March 2023 - The blood thinner Eliquis from BMS, Pfizer's breast cancer drug Ibrance and AbbVie's leukaemia treatment Imbruvica ...
Posted by Michael Wonder on 12 Mar 2023
Medicare doesn’t pay for obesity drugs: lifting this coverage prohibition faces considerable hurdles
11 March 2023 - A number of different stakeholders across the healthcare landscape are lobbying legislators and the Centers for Medicare ...
Posted by Michael Wonder on 12 Mar 2023
Medicare Part D coverage of anti-obesity medications — challenges and uncertainty ahead
11 March 2023 - Obesity is highly prevalent in the United States — affecting more than 41% of adults, including a ...
Posted by Michael Wonder on 08 Mar 2023
Biden calls for tax on the wealthy to extend Medicare funding
8 March 2023 - President Joe Biden this week called for higher taxes on wealthy Americans to extend Medicare funding as ...
Posted by Michael Wonder on 28 Feb 2023
Drugs likely subject to Medicare negotiation (2026-2028)
28 February 2023 - In 2026-2028, we estimate that Medicare will negotiate prices for 38 Medicare Part D drugs and 2 ...
Posted by Michael Wonder on 23 Feb 2023
US Medicare says no change to Alzheimer's drug restrictions
23 February 2023 - The US Government health plan for people over the age of 65 on Wednesday said it ...
Posted by Michael Wonder on 20 Feb 2023
Medicare annual statistics – rolling 12 months (July 2009 to December 2022)
20 February 2023 - This document presents rolling 12 month Medicare statistics by three variables ...
Posted by Michael Wonder on 20 Feb 2023
Senators call on Medicare to offer broad coverage of Alzheimer’s treatments as public pressure grows
17 February 2023 - A group of 20 senators called on Medicare to take action now to offer seniors immediate access ...
Posted by Michael Wonder on 20 Feb 2023
US to select 10 costliest drugs for Medicare pricing negotiation
18 February 2023 - The US Government will select the 10 costliest prescription medicines to Medicare for negotiating prices with ...